Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Macher, Hada C ^a   Suárez Artacho, Gonzalo ^b   Guerrero, Juan M ^a   Gómez Bravo, Miguel A ^b   Álvarez Gómez, Sara ^a   Bernal Bellido, Carmen ^b   Dominguez Pascual, Inmaculada ^a   Rubio, Amalia ^a  

^a Instituto de Biomedicina de Sevilla   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HEMOGLOBIN BETA CHAIN; GENETIC MARKER; SRY PROTEIN, HUMAN; TESTIS DETERMINING FACTOR;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GRAFT RECIPIENT; HEALTH; HEPATIC ARTERY THROMBOSIS; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT; LIVER INJURY; LIVER TRANSPLANTATION; LIVER VEIN THROMBOSIS; MALE; MONITORING; NONALCOHOLIC FATTY LIVER; PRIMARY BILIARY CIRRHOSIS; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION; SRY GENE; AGED; ANTIBODY SPECIFICITY; BLOOD; GENETIC MARKER; GENETICS; GENOMICS; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; Y CHROMOSOME;

ADULT; AGED; BETA-GLOBINS; CHROMOSOMES, HUMAN, Y; DNA; FEMALE; GENETIC MARKERS; GENOMICS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN SPECIFICITY; SEX-DETERMINING REGION Y PROTEIN; TRANSPLANT RECIPIENTS;

EID: 84916910217     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113987     Document Type: Article

References (22)

1. Agopian VG, Petrowsky H, Kaldas FM, Zarrinpar A, Farmer DG, et al. (2013) The evolutions of liver transplantations during 3 decades, analysis of 5347 consecutive liver transplants at a single center. Ann Surg 258: 409-21.
2. Grant A, Neuberger J (1999) Guidelines on the use of liver biopsy in clinical practice. Gut 45(suppl IV): IV 1-IV 11.
3. Millán O, Rafael-Valdivia L, Torrademé E, López A, Fortuna V, et al. (2013) Intracellular IFN-c and IL-2 expression monitoring as surrogate markers of the risk of acute rejection and personal drug response in de novo liver transplant recipients. Cytokine 61(2): 556-64.
4. Vivarelli M, Smith HM, Naoumov NV, Williams R (1995) Quantitative assessment of serum beta-2-microglobulin in liver transplant recipients and relationship to liver graft rejection. Eur J Gastroenterol Hepatol 7(12): 1215-9.
5. Macher H, Egea-Guerrero JJ, Revuelto-Rey J, Gordillo-Escobar E, Enamorado-Enamorado J, et al. (2012) Role of early cell-free DNA levels decrease as a predictive marker of fatal outcome after severe traumatic brain injury. Clin Chim Acta 24(414): 12-7.
6. Snyder TM, Khush KK, Valantine HA, Quake SR (2011) Universal noninvasive detection of solid organ transplant rejection. Proc Natl Acad Sci U S A 108: 6229-34.
7. Beck J, Bierau S, Balzer S, Andag R, Kanzow P, et al. (2013) Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury. Clin Chem 59: 1732-1741.
8. Zhang J, Tong KL, Li PK, Chan AY, Yeung CK, et al. (1999) Presence of donor-and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: Urinary DNA chimerism. Clin Chem 45: 1741-1746.
9. Zhang Z, Ohkohchi N, Okazaki H, Guo Y (2003) Use of PCR and PCR-SSP for detection of urinary donor-origin DNA in renal transplant recipients with acute rejection. Chin Med J (Engl) 116: 191-194.
10. Zhong XY, Hahn D, Troeger C, Klemm A, Stein G, et al. (2001) Cell-free DNA in urine: a marker for kidney graft rejection, but not for prenatal diagnosis? Ann N Y Acad Sci 945: 250-257.
11. García Moreira V, Prieto García B, Baltar Martín JM, Ortega Suárez F, Alvarez FV (2009) Cell-free DNA as a noninvasive acute rejection marker in renal transplantation. Clin Chem 55: 1958-1966.
12. Mortarino Garagiola I, Lotta LA, Siboni SM, Semprini AE, Peyvandi F, et al. (2011) Non-invasive tool for foetal sex determination in early gestational age. Haemophilia 17: 952-6.
13. Macher H, Noguerol P, Medrano-Campillo P, Garrido-Márquez MR, Rubio-Calvo A, et al. (2012) Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving. Clin Chim Acta 18; 413: 490-4.
14. Rainer TH, Wong LKS, Lam W, Yuen E, Lam NYL, et al. (2003) Prognostic use of circulating plasma nucleic acids concentrations in patients with acute stroke. Clin Chem, 49: 562-569.
15. Yu SC, Chan KC, Zheng YW, Jiang P, Liao GJ, et al. (2014) Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing Proc Natl Acad Sci USA May 2 pii: 201406103. [Epub ahead of print]
16. Tong YK, Lo YM (2006) Diagnostic developments involving cell-free (circulating) nucleic acids. Clin Chim Acta 363(1-2): 187-96.
17. Lo YMD, Tein MSC, Pang CCP, Yeung CK, Tong KL, et al. (1998) Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients. Lancet 351: 1329-30.
18. Yu SC, Lee SW, Jiang P, Leung TY, Chan KC, et al. (2013) High-Resolution Profiling of Fetal DNA Clearance from Maternal Plasma by Massively Parallel Sequencing. Clin Chem 59: 1228-37.
19. Gadi VK, Nelson JL, Boespflug ND, Guthrie KA, Kuhr CS (2006) Soluble donor DNA concentrations in recipient serum correlate with pancreas-kidney rejection. Clin Chem 52: 379-82.
20. Lo YM (2011) Transplantation monitoring by plasma DNA sequencing. Clin Chem Jul; 57(7): 941-2. doi: 10.1373/clinchem.2011.166686.
21. Lui YYN, Woo KS, Wang AYM, Yeung CK, Li PKT, et al. (2003) Origin of plasma cell-free DNA after solid organ transplantation. Clin Chem 49: 495-6.
22. Forshew T, Murtaza M, Parkinson C, Gale D, Tsui DW, et al. (2012) Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Transl Med 4: 136ra68.